PubMed

Lipoprotein management in patients with cardiometabolic risk: consensus statement from the American Diabetes Association and the American College of Cardiology Foundation.

Brunzell JD, Davidson M, Furberg CD, Goldberg RB, Howard BV, Stein JH, Witztum JL; American Diabetes Association; American College of Cardiology Foundation.

Diabetes Care. 2008 Apr;31(4):811-22. Review. No abstract available. PMID: 18375431 [PubMed - indexed for MEDLINE]Related articlesFree article

Lipoprotein management in patients with cardiometabolic risk: consensus conference report from the American Diabetes Association and the American College of Cardiology Foundation.

Brunzell JD, Davidson M, Furberg CD, Goldberg RB, Howard BV, Stein JH, Witztum JL.

J Am Coll Cardiol. 2008 Apr 15;51(15):1512-24. Review. No abstract available. PMID: 18402913 [PubMed - indexed for MEDLINE]Related articles

Summaries for patients. Control of lipids in patients with type 2 diabetes: recommendations from the American College of Physicians.

[No authors listed]

Ann Intern Med. 2004 Apr 20;140(8):I85. No abstract available. PMID: 15096362 [PubMed - indexed for MEDLINE]Related articlesFree article

Primary prevention of cardiovascular diseases in people with diabetes mellitus: a scientific statement from the American Heart Association and the American Diabetes Association.

Buse JB, Ginsberg HN, Bakris GL, Clark NG, Costa F, Eckel R, Fonseca V, Gerstein HC, Grundy S, Nesto RW, Pignone MP, Plutzky J, Porte D, Redberg R, Stitzel KF, Stone NJ; American Heart Association; American Diabetes Association.

Diabetes Care. 2007 Jan;30(1):162-72. Review.PMID: 17192355 [PubMed - indexed for MEDLINE]Related articlesFree article

Intensive glycemic control and the prevention of cardiovascular events: implications of the ACCORD, ADVANCE, and VA Diabetes Trials: a position statement of the American Diabetes Association and a Scientific Statement of the American College of Cardiology Foundation and the American Heart Association.

Skyler JS, Bergenstal R, Bonow RO, Buse J, Deedwania P, Gale EA, Howard BV, Kirkman MS, Kosiborod M, Reaven P, Sherwin RS; American Diabetes Association; American College of Cardiology Foundation; American Heart Association.

J Am Coll Cardiol. 2009 Jan 20;53(3):298-304. Review. No abstract available. PMID: 19147051 [PubMed - indexed for MEDLINE]Related articles

Intensive glycemic control and the prevention of cardiovascular events: implications of the ACCORD, ADVANCE, and VA diabetes trials: a position statement of the American Diabetes Association and a scientific statement of the American College of Cardiology Foundation and the American Heart Association: response to Skyler et al.

Lund SS, Vaag AA.

Diabetes Care. 2009 Jul;32(7):e90-1; author reply e92-3. No abstract available. PMID: 19564469 [PubMed - indexed for MEDLINE]Related articlesFree article

Lipid-lowering therapy in patients with type 2 diabetes: the case for early intervention.

Steinmetz A.

Diabetes Metab Res Rev. 2008 May-Jun;24(4):286-93. Review.PMID: 18273835 [PubMed - indexed for MEDLINE]Related articles

Intensive glycemic control and the prevention of cardiovascular events: implications of the ACCORD, ADVANCE, and VA diabetes trials: a position statement of the American Diabetes Association and a scientific statement of the American College of Cardiology Foundation and the American Heart Association.

Skyler JS, Bergenstal R, Bonow RO, Buse J, Deedwania P, Gale EA, Howard BV, Kirkman MS, Kosiborod M, Reaven P, Sherwin RS; American Diabetes Association; American College of Cardiology Foundation; American Heart Association.

Circulation. 2009 Jan 20;119(2):351-7. Epub 2008 Dec 17. Review. No abstract available. Erratum in: Circulation. 2009 Jun 30;119(25):e605. PMID: 19095622 [PubMed - indexed for MEDLINE]Related articles

Cardiovascular disease in diabetes.

Bloomgarden ZT.

Diabetes Care. 2008 Jun;31(6):1260-6. No abstract available. PMID: 18509144 [PubMed - indexed for MEDLINE]Related articlesFree article

Non-HDL cholesterol is less informative than the total-to-HDL cholesterol ratio in predicting cardiovascular risk in type 2 diabetes.

Holman RR, Coleman RL, Shine BS, Stevens RJ.

Diabetes Care. 2005 Jul;28(7):1796-7. No abstract available. PMID: 15983339 [PubMed - indexed for MEDLINE]Related articlesFree article

American Diabetes Association Annual Meeting, 1998: cardiac disease and related topics.

Bloomgarden ZT.

Diabetes Care. 1998 Oct;21(10):1764-73. No abstract available. PMID: 9773745 [PubMed - indexed for MEDLINE]Related articlesFree article

Importance of blood glucose management in the multifactorial approach of absolute cardiovascular risk in type 2 diabetes: the lessons from the Steno 2 study.

Raccah D.

Diabetes Metab. 2006 Sep;32 Spec No2:2S48-51.PMID: 17375408 [PubMed - indexed for MEDLINE]Related articles

Check up America: reduce cardiometabolic risk. Clinical tools of the American Diabetes Association.

Armani AM.

Crit Pathw Cardiol. 2007 Jun;6(2):60-3. No abstract available. PMID: 17667866 [PubMed - indexed for MEDLINE]Related articles

Evaluation of diabetes and cardiovascular disease print patient education materials for use with low-health literate populations.

Hill-Briggs F, Smith AS.

Diabetes Care. 2008 Apr;31(4):667-71. Epub 2008 Jan 17.PMID: 18202245 [PubMed - indexed for MEDLINE]Related articlesFree article

Primary prevention of cardiovascular diseases in people with diabetes mellitus: a scientific statement from the American Heart Association and the American Diabetes Association: response to Buse et al.

Nicolucci A, De Berardis G, Sacco M, Tognoni G.

Diabetes Care. 2007 Jun;30(6):e57; author reply e58. No abstract available. PMID: 17526819 [PubMed - indexed for MEDLINE]Related articlesFree article

Control of cardiovascular risk factors and use of aspirin in diabetic patients remain elusive.

Shrivastava R, Khan A, Jeevanantham V, Nautiyal A, Garg P, Reddy PC.

South Med J. 2008 Jun;101(6):606-11.PMID: 18475221 [PubMed - indexed for MEDLINE]Related articles

Assessment of cardiovascular risk by use of multiple-risk-factor assessment equations: a statement for healthcare professionals from the American Heart Association and the American College of Cardiology.

Grundy SM, Pasternak R, Greenland P, Smith S Jr, Fuster V.

Circulation. 1999 Sep 28;100(13):1481-92. Review. No abstract available. PMID: 10500053 [PubMed - indexed for MEDLINE]Related articlesFree article

Framingham, SCORE, and DECODE risk equations do not provide reliable cardiovascular risk estimates in type 2 diabetes.

Coleman RL, Stevens RJ, Retnakaran R, Holman RR.

Diabetes Care. 2007 May;30(5):1292-3. Epub 2007 Feb 8. No abstract available. PMID: 17290036 [PubMed - indexed for MEDLINE]Related articlesFree article

Glucose control in type 2 diabetes: still worthwhile and worth pursuing.

Kahn SE.

JAMA. 2009 Apr 15;301(15):1590-2. No abstract available. PMID: 19366780 [PubMed - indexed for MEDLINE]Related articles

Molecular mechanisms of diabetic cardiovascular disease.

Hupfeld CJ, Wong GA.

Prev Cardiol. 2002 Fall;5(4):183-7. Review.PMID: 12417827 [PubMed - indexed for MEDLINE]Related articles